SCHEMBL11816596

SCHEMBL11816596

Cc1ncn(-c2nc(Cl)cc3ccccc23)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP2D6 P10635 1/20 0.43
HPGD P15428 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPK1 P28482 1/20 0.35
CYP2A6 P11509 2/20 0.34
GABRG2 P18507 3/20 0.32
GABRB3 P28472 3/20 0.32
GABRA5 P31644 3/20 0.32
GABRA1 P14867 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MAPT P10636 2/20 0.32
LMNA P02545 2/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
MALT1 Q9UDY8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11824198 0.77 CYP2A6 (0.40) ALDH1A1CYP2A6MAPTLMNAHRH4
SCHEMBL11820380 0.75 MKNK1 (0.35) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL11820624 0.73 FAAH (0.40) L3MBTL1LMNA
SCHEMBL11816652 0.73 GABRG2 (0.36) ALDH1A1HPGDGABRG2GABRB3GABRA5
SCHEMBL2170888 0.71 CYP2A6 (0.47) CYP1A2ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL11822572 0.71 KDR (0.44)
SCHEMBL11822511 0.71 GABRG2 (0.36) CYP1A2ALDH1A1CYP2D6GABRG2GABRB3
SCHEMBL11818894 0.70 TSHR (0.40) L3MBTL1MAPTLMNAHRH4
Hydrochloric Acid SCHEMBL9433849 0.70 CYP2A6 (0.45) CYP1A2ALDH1A1HPGDHIF1AHSD17B10
SCHEMBL13316869 0.68 HRH4 (0.42) ALDH1A1LMNAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3961062-A Pharmaceutical composition containing 1-(imidazole-1-yl)-isoquinolines and method of treating hyperlipemia HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-01 US disclosed